Beijing Science Sun Pharmaceutical Co., Ltd.

SZSE:300485.SZ

11.09 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q1
Revenue 105.302108.82382.746121.786139.34132.698135.313215.891191.246192.097241.326287.548288.797233.134302.968306.737317.271167.249312.063343.594340.043195.202488.063366.544302.671270.473265.821220.064155.897108.205147.173165.147167.04136.878150.536165.75158.542132.311149.575166.31156.516117.445
Cost of Revenue 36.84137.16128.23936.27438.35138.07532.61250.18445.50643.30724.47256.84457.56843.24144.5251.93453.05527.83147.99250.78748.90729.10866.148.34142.21739.346.02545.01745.639.32353.52248.77453.70147.29556.91564.461116.89852.6859.24161.562104.2260
Gross Profit 68.46171.66254.50785.511100.98994.623102.701165.707145.74148.79216.854230.705231.229189.893258.448254.803264.216139.418264.07292.808291.136166.094421.962318.203260.454231.173219.795175.048110.29768.88293.652116.372113.33989.58393.621101.28941.64479.63190.334104.74852.29117.445
Gross Profit Ratio 0.650.6590.6590.7020.7250.7130.7590.7680.7620.7750.8990.8020.8010.8150.8530.8310.8330.8340.8460.8520.8560.8510.8650.8680.8610.8550.8270.7950.7080.6370.6360.7050.6790.6540.6220.6110.2630.6020.6040.630.3341
Reseach & Development Expenses 15.669.16823.44511.90415.58126.80421.07630.19432.51516.84723.36723.98534.4422.04928.92217.65213.13911.95832.2728.4066.3663.34-0.18310.48310.16111.466-2.1176.14412.225027.471049.168029.688010.023032.512013.5190
General & Administrative Expenses -7.40113.821-18.49134.538-5.66410.64-24.05631.345-4.4713.5014.30965.315-32.86815.342-23.6514.941-9.17514.831-36.91521.128-8.26812.786-19.90112.693-14.03721.757-25.90213.687-4.1149.77-26.97116.114-8.57813.452-35.8820.08415.23610.67-37.03215.10525.9150
Selling & Marketing Expenses 34.00643.31967.27151.66957.40854.0874.546103.5797.17793.55127.513149.515155.422122.715173.799179.018179.06994.785207.304234.305212.248109.204318.442204.724169.242136.023120.78456.67529.75513.80623.87721.2823.79419.87720.73426.67711.70719.13619.00528.68629.0640
SG&A 26.60557.78448.77986.20651.74464.72150.489134.91592.707107.051131.822214.831122.553138.057150.149193.959169.894109.616170.389255.433203.98121.989298.541217.417155.205157.7894.88270.36225.64123.576-3.09337.39515.21733.329-15.14646.76227.26529.806-18.02743.79155.4390
Other Expenses -0.395-0.00172.478-187.595187.5840.025133.226-139.559139.5320.005149.82818.125-18.131-014.006-0.312-0.022-0.2755.461-1.864-2.586-0.001-0.141-0.008-0.662-1.784-1.2620.001-0.2880.5480.815-0.0720.4790.1170.343-0.08726.719-78.715-15.4611.11813.304-66.742
Operating Expenses 64.48566.952115.22477.74391.37292.327111.53149.966144.972121.306201.573194.903206.796163.773238.594213.945207.276122.821254.768266.376235.727128.112348.959232.49194.124161.081144.75372.49743.63225.52956.22739.6936.12535.08343.19649.67526.719-78.71541.45845.71813.304-66.742
Operating Income 95.8794.71-94.325-61.452275.0992.413-28.43224.912137.201120.955281.03565.73843.62148.60530.93854.25466.09928.62525.6838.86560.15452.46684.56493.90982.04970.24494.33110.49475.08652.47862.9782.04385.29768.64561.23959.34668.36253.59654.80562.80565.59450.704
Operating Income Ratio 0.9110.043-1.14-0.5051.9740.018-0.210.1150.7170.631.1650.2290.1510.2080.1020.1770.2080.1710.0820.1130.1770.2690.1730.2560.2710.260.3550.5020.4820.4850.4280.4970.5110.5020.4070.3580.4310.4050.3660.3780.4190.432
Total Other Income Expenses Net -0.395-138.8170.414-0.0150.0030.0250.002-0.0440.0180.0050.032-0.1130.107-0-0.018-0.312-0.022-0.2750.024-1.864-2.586-0.001-0.141-0.0080.0010.152-1.2620.001-0.2880.5480.849-0.2070.4790.1170.343-0.0870.3080.1350.7471.1180.230.078
Income Before Tax 95.484-134.107-93.911-61.466275.1022.438-28.4324.867137.219120.96281.06765.62543.72848.60530.9253.94266.07828.3525.70537.00157.56752.46684.42393.90182.0570.24493.068110.49574.79853.02663.81981.83785.77668.76261.58259.25968.6753.73155.55363.92365.82450.781
Income Before Tax Ratio 0.907-1.232-1.135-0.5051.9740.018-0.210.1150.7170.631.1650.2280.1510.2080.1020.1760.2080.170.0820.1080.1690.2690.1730.2560.2710.260.350.5020.480.490.4340.4960.5140.5020.4090.3580.4330.4060.3710.3840.4210.432
Income Tax Expense 11.4-32.6942.968-5.20825.9632.03219.1017.29610.42515.14418.88914.7814.3015.9195.88410.5857.643.8974.3834.0539.0347.71511.46215.53810.08510.37211.29316.02714.7977.7396.80212.27712.8479.9218.2548.7179.2177.7887.1839.1439.447.675
Net Income 85.467-190.618-93.608-55.137250.8390.824-47.88818.444127.634106.545264.55752.3842.92442.4125.75444.26559.44125.44421.92233.36248.57144.78472.94178.36171.93959.86681.78294.51560.01645.29256.95469.64272.95658.85553.31150.56859.45345.94248.23954.84256.38443.107
Net Income Ratio 0.812-1.752-1.131-0.4531.80.006-0.3540.0850.6670.5551.0960.1820.1490.1820.0850.1440.1870.1520.070.0970.1430.2290.1490.2140.2380.2210.3080.4290.3850.4190.3870.4220.4370.430.3540.3050.3750.3470.3230.330.360.367
EPS 0.18-0.4-0.19-0.110.520.002-0.0990.0380.270.220.550.110.0890.090.0510.090.140.050.0480.070.10.090.150.160.140.120.170.20.120.0950.120.140.150.130.110.210.170.130.130.150.160.12
EPS Diluted 0.18-0.4-0.19-0.110.520.002-0.0990.0380.270.220.550.110.0890.090.0510.090.140.050.0480.070.10.090.150.160.140.120.170.20.120.0950.120.140.150.130.110.210.170.130.130.150.160.12
EBITDA -55.165155.24233.946-138.22130.4572.931140.317-122.64963.651-45.242342.96537.932-2.00816.65485.79432.78559.6269.1138.72525.0658.80632.02679.44586.37266.9271.32676.21104.55466.80543.47236.88977.46776.81954.72650.55451.618-19.933132.31148.61858.928-7.551117.445
EBITDA Ratio -0.5241.4270.41-1.1350.2190.0221.037-0.5680.333-0.2361.4210.132-0.0070.0710.2830.1070.1880.0540.0280.0730.1730.1640.1630.2360.2210.2640.2870.4750.4290.4020.2510.4690.460.40.3360.311-0.12610.3250.354-0.0481